Avantor, Inc. (AVTR)

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Laboratory Solutions Revenue	-	4.40B	4.61B
Bioscience Production Revenue	-	2.15B	2.17B
Revenue (Total)	6.56B	6.55B	6.78B

Adjusted EBIT

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Corporate Adjusted Operating Income	-66.40M	-70.40M	-66.40M
Operating Income (Other)	-234.70M	-175.80M	1.15B
Operating Income (Total)	-301.10M	-246.20M	1.08B

Adjusted EBIT 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Corporate Adjusted Operating Income	-66.40M	-70.40M	-66.40M
Laboratory Solutions Adjusted Operating Income	-	510.40M	598.00M
Bioscience Production Adjusted Operating Income	-	517.80M	558.20M
Operating Income (Total)	-301.10M	-246.20M	1.08B

Data Source: Fiscal.ai Last updated: Jul 29, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 17, 2026

Data Sources Report a data error